Logo image of ALTM

Arcadium Lithium plc (ALTM) Stock Fundamental Analysis

USA - NYSE:ALTM - JE00BM9HZ112 - Common Stock

5.84 USD
0 (0%)
Last: 3/5/2025, 8:04:00 PM
5.84 USD
0 (0%)
After Hours: 3/5/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, ALTM scores 4 out of 10 in our fundamental rating. ALTM was compared to 83 industry peers in the Chemicals industry. ALTM has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, ALTM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ALTM had positive earnings in the past year.
In the past year ALTM has reported a negative cash flow from operations.
ALTM had positive earnings in 4 of the past 5 years.
ALTM had a positive operating cash flow in 4 of the past 5 years.
ALTM Yearly Net Income VS EBIT VS OCF VS FCFALTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

ALTM has a Return On Assets (1.01%) which is comparable to the rest of the industry.
ALTM has a Return On Equity (1.65%) which is in line with its industry peers.
ALTM has a worse Return On Invested Capital (2.86%) than 63.53% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALTM is above the industry average of 6.34%.
The last Return On Invested Capital (2.86%) for ALTM is well below the 3 year average (8.50%), which needs to be investigated, but indicates that ALTM had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.01%
ROE 1.65%
ROIC 2.86%
ROA(3y)8.14%
ROA(5y)4.55%
ROE(3y)13.03%
ROE(5y)7.26%
ROIC(3y)8.5%
ROIC(5y)N/A
ALTM Yearly ROA, ROE, ROICALTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 10.24%, ALTM belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
In the last couple of years the Profit Margin of ALTM has declined.
The Operating Margin of ALTM (36.16%) is better than 96.47% of its industry peers.
ALTM's Operating Margin has improved in the last couple of years.
The Gross Margin of ALTM (49.37%) is better than 92.94% of its industry peers.
In the last couple of years the Gross Margin of ALTM has grown nicely.
Industry RankSector Rank
OM 36.16%
PM (TTM) 10.24%
GM 49.37%
OM growth 3Y339.85%
OM growth 5Y12.09%
PM growth 3Y315.53%
PM growth 5Y-4.55%
GM growth 3Y27%
GM growth 5Y9.04%
ALTM Yearly Profit, Operating, Gross MarginsALTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALTM is still creating some value.
ALTM has more shares outstanding than it did 1 year ago.
ALTM has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALTM has a worse debt to assets ratio.
ALTM Yearly Shares OutstandingALTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ALTM Yearly Total Debt VS Total AssetsALTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.29, we must say that ALTM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALTM (1.29) is worse than 68.24% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that ALTM is not too dependend on debt financing.
ALTM's Debt to Equity ratio of 0.11 is amongst the best of the industry. ALTM outperforms 83.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACC0.4
WACC7.06%
ALTM Yearly LT Debt VS Equity VS FCFALTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

ALTM has a Current Ratio of 1.09. This is a normal value and indicates that ALTM is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.09, ALTM is not doing good in the industry: 83.53% of the companies in the same industry are doing better.
A Quick Ratio of 0.56 indicates that ALTM may have some problems paying its short term obligations.
ALTM has a Quick ratio of 0.56. This is amonst the worse of the industry: ALTM underperforms 83.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.56
ALTM Yearly Current Assets VS Current LiabilitesALTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

ALTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.56%.
The earnings per share for ALTM have been decreasing by -77.97% on average. This is quite bad
ALTM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.20%.
ALTM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.01% yearly.
EPS 1Y (TTM)-94.56%
EPS 3YN/A
EPS 5Y-77.97%
EPS Q2Q%-97.06%
Revenue 1Y (TTM)14.2%
Revenue growth 3Y33.84%
Revenue growth 5Y21.01%
Sales Q2Q%58.97%

3.2 Future

The Earnings Per Share is expected to grow by 53.89% on average over the next years. This is a very strong growth
ALTM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.62% yearly.
EPS Next Y11.36%
EPS Next 2Y51.71%
EPS Next 3Y62.79%
EPS Next 5Y53.89%
Revenue Next Year15.71%
Revenue Next 2Y16.95%
Revenue Next 3Y27.33%
Revenue Next 5Y16.62%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALTM Yearly Revenue VS EstimatesALTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
ALTM Yearly EPS VS EstimatesALTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50 100 150 200 250

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 44.92 indicates a quite expensive valuation of ALTM.
Compared to the rest of the industry, the Price/Earnings ratio of ALTM indicates a slightly more expensive valuation: ALTM is more expensive than 65.88% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ALTM to the average of the S&P500 Index (27.38), we can say ALTM is valued expensively.
Based on the Price/Forward Earnings ratio of 40.34, the valuation of ALTM can be described as expensive.
Based on the Price/Forward Earnings ratio, ALTM is valued a bit more expensive than 68.24% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, ALTM is valued quite expensively.
Industry RankSector Rank
PE 44.92
Fwd PE 40.34
ALTM Price Earnings VS Forward Price EarningsALTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

62.35% of the companies in the same industry are cheaper than ALTM, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.62
ALTM Per share dataALTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of ALTM may justify a higher PE ratio.
ALTM's earnings are expected to grow with 62.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.95
PEG (5Y)N/A
EPS Next 2Y51.71%
EPS Next 3Y62.79%

More info and screens

0

5. Dividend

5.1 Amount

ALTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Arcadium Lithium plc

NYSE:ALTM (3/5/2025, 8:04:00 PM)

After market: 5.84 0 (0%)

5.84

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners71.08%
Inst Owner Change8.26%
Ins Owners0.22%
Ins Owner Change0%
Market Cap6.27B
Analysts70
Price Target6.03 (3.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-39.28%
Min EPS beat(2)-74.86%
Max EPS beat(2)-3.69%
EPS beat(4)1
Avg EPS beat(4)-11.38%
Min EPS beat(4)-74.86%
Max EPS beat(4)34.36%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-10.28%
Min Revenue beat(2)-25.87%
Max Revenue beat(2)5.31%
Revenue beat(4)2
Avg Revenue beat(4)-7.56%
Min Revenue beat(4)-25.87%
Max Revenue beat(4)5.31%
Revenue beat(8)5
Avg Revenue beat(8)295.85%
Revenue beat(12)9
Avg Revenue beat(12)401.08%
Revenue beat(16)13
Avg Revenue beat(16)354.95%
PT rev (1m)0%
PT rev (3m)-3.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)119.38%
EPS NY rev (1m)0%
EPS NY rev (3m)1.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.96%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)-5.29%
Valuation
Industry RankSector Rank
PE 44.92
Fwd PE 40.34
P/S 6.22
P/FCF N/A
P/OCF N/A
P/B 1
P/tB 1.3
EV/EBITDA 14.62
EPS(TTM)0.13
EY2.23%
EPS(NY)0.14
Fwd EY2.48%
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.94
BVpS5.83
TBVpS4.5
PEG (NY)3.95
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.01%
ROE 1.65%
ROCE 3.88%
ROIC 2.86%
ROICexc 2.89%
ROICexgc 3.41%
OM 36.16%
PM (TTM) 10.24%
GM 49.37%
FCFM N/A
ROA(3y)8.14%
ROA(5y)4.55%
ROE(3y)13.03%
ROE(5y)7.26%
ROIC(3y)8.5%
ROIC(5y)N/A
ROICexc(3y)10.83%
ROICexc(5y)N/A
ROICexgc(3y)11.51%
ROICexgc(5y)N/A
ROCE(3y)11.53%
ROCE(5y)N/A
ROICexcg growth 3Y191.49%
ROICexcg growth 5Y-15.97%
ROICexc growth 3Y175.9%
ROICexc growth 5Y-18.7%
OM growth 3Y339.85%
OM growth 5Y12.09%
PM growth 3Y315.53%
PM growth 5Y-4.55%
GM growth 3Y27%
GM growth 5Y9.04%
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 1.38
Cap/Depr 841.13%
Cap/Sales 103.49%
Interest Coverage 12.57
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.56
Altman-Z 1.29
F-Score2
WACC7.06%
ROIC/WACC0.4
Cap/Depr(3y)1054.15%
Cap/Depr(5y)836.79%
Cap/Sales(3y)60.66%
Cap/Sales(5y)51.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.56%
EPS 3YN/A
EPS 5Y-77.97%
EPS Q2Q%-97.06%
EPS Next Y11.36%
EPS Next 2Y51.71%
EPS Next 3Y62.79%
EPS Next 5Y53.89%
Revenue 1Y (TTM)14.2%
Revenue growth 3Y33.84%
Revenue growth 5Y21.01%
Sales Q2Q%58.97%
Revenue Next Year15.71%
Revenue Next 2Y16.95%
Revenue Next 3Y27.33%
Revenue Next 5Y16.62%
EBIT growth 1Y-8.97%
EBIT growth 3Y488.68%
EBIT growth 5Y35.64%
EBIT Next Year99.7%
EBIT Next 3Y72.01%
EBIT Next 5Y51.11%
FCF growth 1Y-3990.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-159.2%
OCF growth 3YN/A
OCF growth 5YN/A